Home ›
Trademark Categories ›
Pharmaceuticals ›
2016 ›
AB ›
ABUSAFE
Trademark search for:
ABUSAFE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2016-05-12 — Application filed
2016-09-01 — Sn assigned for sect 66a appl from ib
2016-09-06 — Application filed
2016-09-06 — Assigned to examiner
2016-09-10 — Application filed
2016-09-13 — Final disposition recorded
2016-09-14 — Office action issued
2016-09-15 — Office action issued
2016-09-15 — Office action issued
2016-10-02 — Office action issued
2017-03-13 — Teas/email correspondence entered
2017-03-13 — Office action issued
2017-03-13 — Correspondence received in law office
2017-03-15 — Approved for pub - principal register
2017-04-05 — Notification of possible opposition sent to ib
2017-04-05 — Notification of notice of publication e-mailed
2017-04-05 — Notice of start of opposition period created, to be sent to ib
2017-04-22 — Notification processed by ib
2017-04-25 — Published for opposition
2017-04-25 — Official gazette publication confirmation e-mailed
2017-07-11 — Registered-principal register
2017-10-11 — Final disposition recorded
2017-10-16 — Final disposition recorded
2017-10-16 — Final disposition recorded
2017-11-04 — Final disposition recorded
2021-11-26 — New representative at ib received
2022-07-11 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2023-11-04 — New representative at ib received
2024-01-26 — Cancelled section 71
2024-01-26 — Final status recorded
2024-09-27 — Total invalidation of reg ext protection created
2024-10-02 — Total invalidation of reg ext protection sent to ib
2024-10-02 — Invalidation processed
2024-10-18 — Total invalidation processed by the ib
Owner Information
G.L. Pharma GmbH
G.L. Pharma GmbH
G.L. Pharma GmbH
Correspondent
Lawrence E. Abelman Abelman Frayne & Schwab
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
